ArticleBMJ open2023

Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study.

Emily Susannah Mander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.